Covalent lipid modifications of proteins  by Resh, Marilyn D.
Magazine
R431
Is it fair to say that Micromalthus 
is an ancient, primitive beetle? 
Many of Micromalthus’ anatomical 
characters are indeed primitive, in 
the sense of resembling the most 
recent ancestor it shares with other 
beetles, but of course its life cycle 
is anything but. No one thinks the 
ancestral beetle — or the ancestors 
of any other living beetles — had 
Micromalthus’ bizarre genetic and 
developmental system. Micromalthus 
can be seen as a particularly extreme 
example of ‘mosaic evolution’ — the 
evolution of different characters 
at different rates — and of why it’s 
probably not a good idea to call any 
species ‘primitive’ even if it looks that 
way superficially.
Is Micromalthus unique? Some 
species of fungus gnats and gall 
midges resemble Micromalthus in 
many ways: they live in rotting wood 
feeding on fungi and have a complex 
life cycle in which most reproduction 
consists of paedogenetic larvae 
giving birth to more larvae. But larvae 
of these species don’t eat their own 
mothers. Some species in the recently-
discovered marine phylum Loricifera 
turn out to have complex life cycles 
with paedogenic larvae and mother-
eating, but it is the females that eat 
their mothers, males are still unknown. 
Male-specific maternal cannibalism 
seems to have been found only in 
Micromalthus. So far.
Where can I find out more?
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Covalent lipid 
modifications of 
proteins 
Marilyn D. Resh
Attachment of lipophilic groups 
is a widespread modification that 
occurs on nearly 1,000 proteins of 
diverse structure and function. At 
least five different types of lipids 
can be covalently attached to 
proteins: fatty acids, isoprenoids, 
sterols, phospholipids, and 
glycosylphosphatidyl inositol (GPI) 
anchors. Proteins can contain 
more than one type of lipid, e.g. 
myristate + palmitate, palmitate + 
cholesterol, or farnesyl + palmitate. 
An important principle derived from 
studies of lipid-modified proteins 
is that not all fat is the same. Each 
type of lipid moiety is attached by 
a different lipid transferase and 
each modification confers distinct 
properties to the modified protein. 
The most common outcome of lipid 
modification is an increased affinity 
for membranes. However, attachment 
of myristoyl or prenyl groups can 
also promote intramolecular and 
intermolecular protein–protein 
interactions. Another key concept 
is reversibility. The covalent linkage 
between a protein and either 
thioester-linked palmitate or a GPI 
anchor can be broken by the actions 
of thioesterases and phospholipases, 
respectively. By contrast, neither 
myristate nor the isoprenoids farnesyl 
or geranylgeranyl are physically 
removed from a modified protein. 
Instead, Mother Nature has devised 
a clever means for some proteins 
to sequester these lipophilic groups 
within a hydrophobic cleft, effectively 
shielding them from the aqueous 
milieu. Here, I provide an overview 
of the structural and functional 
consequences for proteins containing 
each type of lipid modification 
(depicted in Figure 1). 
N-myristoylation of proteins
Proteins that are destined to be 
covalently modified with the 14-
carbon saturated fatty acid myristate 
generally contain the sequence Met–Gly–X–X–X–Ser/Thr at the amino 
terminus. In eukaryotes, 0.5–0.8% 
of all proteins are predicted to 
be N-myristoylated. Web-based 
algorithms are available to analyze 
whether a particular amino-
terminal sequence is likely to be 
modified, e.g. http://mendel.imp.
ac.at/myristate/SUPLpredictor.htm; 
http://web.expasy.org/myristoylator/. 
After removal of the initiating Met 
by methionine aminopeptidase, 
myristate is attached to the amino-
terminal Gly. No other residue can 
substitute for Gly at the amino 
terminus, and mutants with a Gly-
to-Ala substitution are often used as 
non-myristoylated, negative controls 
for determining the effect of  
N-myristoylation on a particular protein.
N-myristoylation is catalyzed by 
N-myristoyl transferase (NMT), a 
50 kDa cytosolic enzyme that is 
expressed in most organisms as one 
or two gene products (e.g. NMT1 
and NMT2 in humans). The reaction 
typically occurs co-translationally, 
and is facilitated by binding of 
NMT to ribosomes. However, post-
translational myristoylation of 
proteins can occur during apoptosis, 
when caspase cleavage exposes a 
cryptic myristoylation site. In addition 
to the target protein, the other 
substrate for NMT is myristoyl-CoA. 
Catalysis proceeds via an ordered 
reaction mechanism: myristoyl CoA 
binds to the enzyme first, followed by 
the target protein to form a ternary 
complex. Myristate is transferred 
to the protein, CoA is released, and 
finally the myristoylated protein 
is released. The linkage between 
myristate and the protein is an amide 
bond, which is extremely stable. 
Myristate therefore remains attached 
to the modified protein throughout its 
lifetime and a pool of endogenous, 
non-myristoylated protein does not 
generally exist in cells. Detection 
methods for N-myristoylated proteins 
include mass spectrometric analysis 
of the purified protein, or analysis 
of proteins in cells labeled with 
radiolabeled fatty acids or with 
alkyne- or azide-linked fatty acids 
in combination with Cu(I)-catalyzed 
click chemistry.
One of the major functions of 
myristate is to assist in directing the 
modified protein to membranes. A 
central tenet, originally established 
by Peitzsch and McLaughlin, is that 
myristate alone is not sufficiently 
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Figure 1. Localization and regulation of lipid-modified proteins.
Conceptual diagram of representative proteins modified with various lipophilic groups. Lipid 
rafts (blue bilayer) are enriched in GPI-anchored proteins (green) on the outer leaflet, and palmi-
toylated proteins (blue) on the inner leaflet. GPI-anchored proteins can be released from the cell 
by phospholipases. Depalmitoylation by palmitoyl thioesterases (PTEs) releases palmitoylated 
proteins from the cytoplasmic side of the membrane. N-myristoylated proteins (red) can un-
dergo a myristoyl switch and dissociate from the membrane.  H-Ras, a protein modified with 
farnesyl and palmitate (purple), localizes to both the plasma membrane and the Golgi. H-Ras 
can be released from the plasma membrane by depalmitoylation, rebind to the Golgi, where 
it is repalmitoylated, and then undergo vesicular trafficking back to the plasma membrane. 
Geranylgeranylated proteins (light purple) can be extracted from the bilayer by the action of 
guanine nucleotide dissociation inhibitors (GDIs). A secreted protein that is lipid modified is 
represented by Hh (yellow). Hh is modified by palmitate and cholesterol in the endoplasmic 
reticulum (ER), traffics through the secretory pathway, and is released from the cell. hydrophobic to stably anchor a 
protein to a lipid bilayer within 
a cell. A second signal, either a 
cluster of positively charged amino 
acids or hydrophobic residues or 
a covalently attached palmitate 
moiety, is required for stable 
membrane binding. Polybasic 
domains within myristoylated 
proteins interact electrostatically with 
negatively charged phospholipids 
(typically phosphatidylserine or 
phosphatidylinositolphosphates) 
that are enriched on the cytoplasmic 
leaflets of the plasma membrane 
and intracellular membranes. 
Proteins that utilize this type of 
‘myristate+basic’ motif to achieve 
membrane binding include  
c-Src, HIV-1 Gag, MARCKS, and 
hisactophilin (Table 1). For the small 
G protein Arf1, membrane association is enhanced when hydrophobic 
residues in the amino-terminal helix 
cooperate with myristate. The second 
signal for membrane binding of 
myristoylated proteins, such as Src 
family kinases, several Ga subunits, 
and A-kinase anchoring proteins 
(AKAPs), is provided by palmitate, 
which is attached to one or more 
cysteine residues within the amino-
terminal region. Interaction of a 
myristoylated protein with a particular 
membrane can also be indirect. For 
example, UNC119 proteins bind a 
subset of N-myristoylated proteins 
and function as chaperones to deliver 
these proteins to distinct membrane 
structures such as the rod outer 
segment or cilia. 
Not all myristoylated proteins 
are membrane bound, and there 
are numerous examples (e.g. cAMP-dependent protein kinase, 
methionine sulfoxide reductase A) 
of cytosolic, myristoylated proteins. 
Myristate can be buried in a 
hydrophobic cleft within the modified 
protein, where it may play a critical 
role in regulating intrinsic thermal 
stability, enzymatic activity, and/or 
protein stability. In some proteins, 
exposure of the myristate moiety 
is regulated by an intramolecular 
‘myristoyl-switch’ that allows 
the protein to undergo reversible 
membrane binding (Figure 1). The 
switch can be triggered by binding 
of ligands or drugs or by protein 
multimerization, thereby regulating 
the distribution of the modified 
protein between cytosolic and 
membrane-bound states. 
S-palmitoylation, N-palmitoylation 
and other fatty acid and sterol 
modifications
Attachment of the 16-carbon 
fatty acid palmitate to proteins 
is a common, post-translational 
modification. Detection methods 
include radiolabeling of cells with 
3H- or 125I-iodo fatty acids, acylbiotin 
exchange, mass spectrometry, or click 
chemistry techniques. Palmitoylation 
can occur on peripheral membrane 
proteins, either alone or in addition 
to N-myristoylation or prenylation, 
as well as on transmembrane 
proteins (Table 1). The functions of 
protein palmitoylation are diverse, 
and include membrane binding, 
lipid raft localization, protein 
trafficking and stability. Nearly all 
palmitoylated proteins are modified 
by attachment of the fatty acid to 
a cysteine residue via thioester 
linkage (S-palmitoylation). A family 
of cysteine-rich domain palmitoyl 
acyltransferases (PATs), termed  
DHHC for the conserved sequence  
Asp–His–His–Cys in the active  
site, is primarily responsible for  
S-palmitoylation of intracellular 
proteins in organisms ranging 
from yeast (7 family members in 
Saccharomyces cerevisiae) to humans 
(23 family members). DHHC PATs are 
multipass membrane proteins with 
between four and six transmembrane 
domains and are localized to the 
endoplasmic reticulum (ER), the Golgi, 
or the plasma membrane. Transfer of 
palmitate from the donor — palmitoyl 
CoA — to the protein substrate 
proceeds via an acyl enzyme 
intermediate. Some DHHC enzymes 
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Table 1. Representative lipid-modified proteins.
Lipid 1 Lipid 2 Protein Localization Notes
Myristate Protein kinase A, catalytic 
subunit
Cytosolic Myristate is sequestered in a 
hydrophobic cleft within the 
protein 
Myristate MARCKS Plasma membrane/cytoskeleton Phosphorylation within the 
polybasic motif releases 
MARCKS from the membrane
Myristate ARF1 Golgi<-->cytosol GTP/GDP binding induces a 
myristoyl switch
Myristate c-Src Plasma membrane/endosomes Binds to membranes via a 
myristate+basic motif
Myristate Palmitate Src family kinases (SFKs) Plasma membrane/endosomes SFKs are acylated with one or 
two palmitates in addition to 
myristate
Myristate Palmitate Ga subunits Plasma membrane/cytosol Associate with Gbg subunits
Myristate Palmitate AKAPs Plasma membrane/intracellular  
organelles
Scaffolding proteins for protein 
kinase A
Palmitate Transferrin receptor Plasma membrane Transmembrane protein
Palmitate GPCRs Plasma membrane Transmembrane proteins; 
palmitate regulates cell-surface 
delivery, stability and signaling
Palmitate PSD95 Postsynaptic density (PSD) Scaffolding protein that 
concentrates receptors in the 
PSD
Palmitate Cholesterol Hedgehogs (Sonic,  
Indian, Desert)
Secretory pathway, extracellular space Secreted morphogens involved 
in embryo patterning and 
tumorigenesis
Palmitoleate Wnts Secretory pathway, extracellular space Secreted morphogens involved 
in embryo patterning and 
tumorigenesis
Oleate Ghrelin Secretory pathway, extracellular space Appetite-stimulating hormone
Farnesyl Palmitate H-Ras, N-Ras Plasma membrane, Golgi Undergo continuous cycles 
of palmitoylation and 
depalmitoylation
Farnesyl K-Ras4B Plasma membrane Binds to membranes via a 
farnesyl+basic motif
Farnesyl LaminB Nuclear envelope Mutated in progeria
Geranylgeranyl Rab and Rho GTPases Plasma membrane, Golgi, intracellular 
vesicles
Can be extracted from membranes 
by GDIs
Phosphatidylethanolamine Atg8/LC3 Autophagosome Regulates double membrane 
formation during autophagy
GPI anchor NCAM Outer leaflet of plasma membrane Neural cell adhesion molecule
GPI anchor 5’ Nucleotidase Outer leaflet of plasma membrane Cell surface hydrolase
GPI anchor CD55 Outer leaflet of plasma membrane Complement regulatory protein
GPI anchor Thy1 Outer leaflet of plasma membrane Cell-surface antigenexhibit fatty acyl CoA chain length 
preferences, which may explain why 
longer chain fatty acids, such as 
stearate, oleate and arachidonate, are 
also found attached to proteins. There 
is no consensus sequence within the 
target protein for DHHC-mediated 
palmitoylation. Moreover, some 
proteins are apparently modified by 
a single DHHC, whereas others are 
substrates for multiple DHHC PATs. 
A key feature of thio-ester 
linked fatty acylation is that the 
modification is reversible. Thus, 
dynamic cycles of palmitoylation 
via PATs and depalmitoylation via 
palmitoyl protein thioesterases (PTEs) 
occur, enabling proteins to undergo 
reversible cycles of membrane 
association and dissociation within the cell. For H-Ras and N-Ras, a 
continuous acylation/deacylation 
cycle is required for these proteins to 
localize and signal from two different 
intracellular locations — the plasma 
membrane and the Golgi (Figure 1). 
When depalmitoylation is blocked, 
by inhibiting acyl protein thioesterase 
1, H-Ras and N-Ras become 
mislocalized, randomly redistribute 
amongst all endomembranes, and 
signal transduction is reduced. 
Other palmitoylated proteins, such 
as R7BP and Wrch-1, use cycles 
of palmitoylation/depalmitoylation 
to translocate from the plasma 
membrane to the nucleus. 
The saturated nature of the fatty 
acyl chain, coupled with its chain 
length, enable palmitate to serve as a major driving force for proteins 
to associate with lipid rafts. These 
specialized membrane subdomains 
are enriched in glycosphingolipids and 
cholesterol, as well as phospholipids 
acylated with saturated fatty acids. 
The unique lipid composition of 
rafts promotes formation of a ‘liquid 
ordered’ domain that segregates 
from the bulk of the lipids in the 
plasma membrane. Palmitoylated 
proteins, such as Src family kinases, 
preferentially associate with and 
signal from rafts, and substitution 
with unsaturated fatty acids inhibits 
signaling (Figure 1). The situation 
is not as clear for palmitoylated 
transmembrane proteins: some 
associate with lipid rafts whereas 
others do not. 
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attachment, N-palmitoylation, 
occurs in Hedgehog (Hh) proteins. 
These secreted proteins function as 
morphogens and are highly active 
during embryonic development as well 
as in tumor formation in adults. Hh 
proteins undergo a series of unique 
modifications (Figure 1). Following 
entry into the lumen of the ER and 
cleavage of the signal sequence, 
Hh proteins are cut in half via 
autoprocessing. The amino-terminal 
19 kDa fragment resulting from the 
autocleavage reaction is modified 
by attachment of cholesterol to its 
carboxyl terminus (discussed below) 
and palmitate to its amino-terminal 
Cys residue. Unlike S-palmitoylated 
proteins, the linkage between palmitate 
and Hh is an amide bond. The enzyme 
that catalyzes N-palmitoylation of Hh 
proteins is Hedgehog acyltransferase 
(Hhat), a multipass membrane protein 
that is a member of the membrane 
bound O-acyl transferase (MBOAT) 
family. Palmitoylation of Hh by Hhat 
is essential for its activity during 
development. In addition, Hhat 
activity is required for Hh signaling 
in tumorigenesis, and specific 
inhibitors of Hhat that block cancer 
cell proliferation have recently been 
described. 
To date, Hh is the only family of 
proteins known to be covalently 
modified by cholesterol, although 
others have been postulated to exist. 
This modification occurs during 
autoprocessing: the 3b-hydroxyl group 
of cholesterol acts as a nucleophile to 
break a thioester intermediate formed 
during the autocleavage reaction. As a 
result, cholesterol becomes linked to 
the carboxy-terminal Gly of Hh via an 
ester bond. Cholesterol modification 
regulates the ability of Hh proteins to 
diffuse during development, and has 
been shown to play a role in both long-
range and short-range Hh signaling. 
Another MBOAT family member, 
Porcupine (Porcn), is responsible for 
attaching a palmitate derivative to 
Wnt proteins. A monounsaturated 
fatty acid, palmitoleate, is linked to a 
Ser residue that is conserved within 
all mammalian Wnt proteins (Ser209 
in Wnt3a; Table 1). Attachment of 
palmitoleate is required for three steps 
in Wnt protein biogenesis: binding 
to Wntless, a protein that mediates 
Wnt intracellular transport; secretion 
of Wnt proteins into the extracellular 
milieu; and binding of Wnt to its receptor Frizzled. Small-molecule 
inhibitors that block Porcn-mediated 
Wnt modification and Wnt signaling 
have been reported and have recently 
been shown to exhibit therapeutic 
efficacy in treating Wnt-driven 
cancers. 
A third member of the MBOAT family,
ghrelin acyltransferase (GOAT), uses 
an 8-carbon fatty acid, octanoate, as 
a substrate (Table 1). GOAT catalyzes 
attachment of octanoate to Ser3 of 
ghrelin, a secreted peptide hormone. 
Octanoylation of ghrelin is required for 
its activity as an appetite-stimulating 
factor. Thus, GOAT is an attractive 
therapeutic target for treatment 
of diseases such as obesity and 
diabetes. 
Farnesylation and 
geranylgeranylation of proteins
Farnesyl and geranylgeranyl are 
15-carbon and 20-carbon isoprenoid 
groups, respectively, that are attached 
post-translationally to proteins 
(Table 1). The prenylation reaction 
occurs in the cytosol, and results 
in a thio-ether linkage between the 
isoprenoid and a cysteine residue 
at or near the carboxyl terminus of 
the modified protein. A hallmark 
of most prenylated proteins is the 
presence of a ‘CAAX’ box (Cys–
aliphatic–aliphatic–X) at the carboxyl 
terminus, where the ‘X’ amino acid 
specifies whether the protein will 
be modified by farnesyl transferase 
(FTase) or geranylgeranyl transferase 
I (GGTase I). The two enzymes are 
related: both are ab heterodimers 
that share the same a subunit but 
have a different b subunit. Prenylation 
enhances the interaction of the 
modified protein with the ER, where 
two additional processing steps take 
place. Ras converting enzyme I (RceI) 
proteolytically removes the ‘AAX’ 
sequence, then isoprenylcysteine 
carboxymethyltransferase (Icmt) 
carboxymethylates the newly 
generated carboxy-terminal Cys. 
Further modification of prenylated 
proteins can also occur. In the case of 
Ras proteins, palmitate is attached to 
one (N-Ras) or two (H-Ras) cysteines 
located upstream of the farnesylated 
Cys. Interestingly, proteins with a 
double Cys motif in their CAAX box 
(e.g. CCIF in a brain-specific Cdc42 
variant) have recently been shown to 
bypass AAX processing, and instead 
undergo palmitoylation, resulting in 
tandem palmitoylation and prenylation  
at the two adjacent cysteines. A 
subclass of prenylated proteins is 
typified by geranylgeranylated Rab 
proteins, which contain CXC or CC 
sequences at their carboxyl termini. 
Both cysteines are prenylated by 
GGTase II, which works in concert 
with Rab escort protein (REP). 
Rab GTPases that end in CXC can 
also undergo carboxy-terminal 
carboxymethylation. 
The geranylgeranyl group is 
sufficiently hydrophobic to anchor 
the modified protein to a membrane, 
whereas farnesyl is not. Similar to 
myristoylated proteins, farnesylated 
proteins require a second signal 
for stable membrane interaction, 
typically palmitate (as in H-Ras) or 
a polybasic cluster (as in KRas4B). 
The use of two signals allows for 
reversible membrane association. 
Farnesyl+palmitate-containing 
proteins can be removed from the 
membrane by depalmitoylation, as 
discussed earlier for H- and N-Ras, 
whereas phosphorylation within 
the polybasic motif can reduce the 
electrostatic component of binding 
for proteins such as K-Ras4B or Rnd3 
and result in membrane dissociation. 
Geranylgeranylated proteins such 
as Rab and Rho GTPases can also 
be removed from the membrane. In 
this case, the prenyl group facilitates 
protein–protein interactions with 
guanine nucleotide dissociation 
inhibitors (GDIs; Figure 1). GDI 
proteins contain a hydrophobic 
groove that binds and sequesters 
the geranylgeranyl moiety, thereby 
allowing GDIs to extract Rab and 
Rho proteins from the membrane and 
redistribute them into the cytosol, 
where they are inactivated. 
Protein prenylation and associated 
modifications are essential for normal 
cell function. Deficiency of FTase, 
Rce1 or Icmt is lethal in mice, and 
mutations in REP cause blindness in 
humans. Protein prenylation enzymes 
are also clinical targets in disease. For 
example, farnesylation is necessary 
in order for Ras proteins to bind to 
membranes and, when activated, to 
induce cell transformation in vitro and 
tumorigenesis in vivo. These findings 
led to the development of farnesyl 
transferase inhibitors (FTIs) with the 
goal of exploiting them as anti-cancer 
agents. Unfortunately, FTIs have 
failed to treat cancer in the clinic, 
primarily because K-Ras, the most 
commonly mutated Ras protein in 
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of the FTI by instead undergoing 
geranylgeranylation. However, FTIs 
have proved effective in targeting 
progerin, a mutant form of lamin A 
involved in the rare premature aging 
disorder Hutchinson-Gilford progeria 
syndrome. Farnesylation of the lamin 
A precursor is required for a cleavage 
event that normally removes the 
farnesylated carboxy-terminal tail 
and allows mature lamin A to insert 
correctly into the nuclear lamina. The 
mutant progerin is not cleaved and 
remains farnesylated, resulting in 
abnormal nuclear envelope structure 
that leads to progeria. Treatment 
with FTIs has recently shown clinical 
efficacy both in mouse models of 
progeria and, importantly, in children 
suffering from the disease. 
Phospholipid conjugation during 
autophagy
To date, there is one known example 
of a protein that is attached directly to 
a phospholipid: the yeast protein Atg8, 
and its mammalian homolog LC3 
(Table 1). Lipidation occurs through 
a series of ubiquitin-like conjugation 
steps catalyzed by autophagy-related 
(Atg) proteins. The carboxy-terminal 
Arg of Atg8 is cleaved by Atg4 to 
expose Gly at the Atg8 carboxyl 
terminus, which is then linked to 
Atg7, transferred to Atg3, and finally 
conjugated to the phospholipid 
phosphatidylethanolamine (PE) via 
an amide bond. These reactions 
occur on the newly forming 
autophagosome membrane and serve 
to regulate growth and closure of 
this double membrane organelle. As 
the autophagosome matures, PE is 
removed from Atg8 by the action of 
Atg4. 
Glycosylphosphatidylinositol (GPI) 
anchors
Approximately 1% of all eukaryotic 
proteins are modified by a complex 
lipid structure known as the GPI 
anchor (Table 1). Assembly of the 
anchor and transfer to the protein 
occurs in the ER and is mediated 
by nearly two dozen different 
enzymes. The protein destined to be 
modified contains a carboxy-terminal 
recognition sequence that is cleaved 
and replaced with an anchor structure 
containing PE (which is linked to the 
protein carboxyl terminus), three 
mannoses, glucosamine, and an 
inositol phospholipid. The anchor can be further remodeled, by replacement 
of the fatty acid substituents on the 
inositol phospholipid with long-chain, 
saturated fatty acids. Loss of critical 
enzymes in the GPI biosynthetic 
pathway is lethal in organisms ranging 
from yeast to parasites to mice. 
GPI-modified proteins in the ER are 
recruited to COPII-coated vesicles 
through interaction with members 
of the p24 family of cargo receptors. 
In yeast, GPI-anchored proteins 
are sorted into specialized vesicles 
distinct from vesicles used for other 
secreted proteins, but this type of 
vesicular segregation may not occur 
in mammalian cells. After transfer from 
the ER to the Golgi and trafficking 
through the secretory pathway, the 
proteins are inserted into the outer, 
extracellular leaflet of the plasma 
membrane via the phosphatidylinositol 
(PI) moiety. In polarized cells, 
attachment of a GPI anchor generally 
serves as a trafficking signal to target 
proteins to the apical surface. The 
saturated nature of the fatty acids 
attached to the PI moiety enhances 
insertion of GPI-anchored proteins into 
lipid raft domains (Figure 1), where they 
participate in a wide variety of signal 
transduction pathways.
Since the GPI anchor is covalently 
attached to the protein via an amide 
bond, and PI strongly inserts into the 
outer bilayer leaflet, one can view the 
GPI anchor as a mechanism to stably 
anchor a protein to the extracellular 
side of the plasma membrane. 
However, GPI-anchored proteins have 
been observed to ‘hop’ from one cell 
to another via intermembrane transfer, 
both in vitro and in vivo. Moreover, 
some GPI anchors are susceptible 
to cleavage in vitro by PI-specific 
phospholipase C, which removes 
the diacylglycerol group and results 
in release of the protein from the 
membrane. It is unclear whether this 
process also occurs in vivo and, if 
so, how it is regulated. The structural 
complexity of the GPI anchor as well 
as its heterogeneous nature have 
made it difficult to define its exact 
biological functions. 
Perspectives
Mother Nature has devised a wide 
array of options for proteins to 
exploit hydrophobic moieties as a 
means to promote protein–lipid and 
protein–protein interactions. The 
ability of lipid-modified proteins to 
reversibly associate with membranes provides an additional mechanism 
to regulate signal transduction. As 
our knowledge of the biochemistry 
and cell biology of lipid modification 
continues to grow, more proteins that 
contain these modifications will be 
identified and we will need to continue 
to try to deduce the effects of lipid 
attachment on protein structure and 
function. The technical difficulties in 
obtaining three-dimensional structures 
of lipid-modified proteins continues 
to be a challenge. However, highly 
informative structures of proteins 
with their lipid moieties attached 
have emerged (e.g. myristoylated 
ARF1, myristoylated recoverin, 
geranylgeranylated Rab bound to 
RabGDI, and palmitoleoylated Wnt8 
bound to its receptor Frizzled). 
Moreover, the development of drugs 
that specifically inhibit protein 
myristoylation, palmitoylation and 
prenylation has provided therapeutic 
tools that are being exploited to 
attack lipidated proteins involved in 
pathogen-mediated infection, cancers 
and other disease states. 
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